
Microbiome Testing Kit Market Report 2026
Global Outlook – By Product Type (At-Home Testing, Laboratory-Based Testing), By Sample Type (Stool, Saliva, Skin, Other Sample Types), By Application (Gut Health, Skin Health, Nutrition And Diet, Disease Risk Assessment, Other Applications), By Distribution Channel (Online, Pharmacies, Retail Stores, Other Distribution Channel), By End-User (Individuals, Hospitals And Clinics, Research And Academic Institutes, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035
Microbiome Testing Kit Market Overview
• Microbiome Testing Kit market size has reached to $1.63 billion in 2025 • Expected to grow to $4.8 billion in 2030 at a compound annual growth rate (CAGR) of 24% • Growth Driver: Increasing Demand For Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomics And Tailored Health Management • Market Trend: Next-Generation Sequencing Enables Personalized Gut Health Insights • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Microbiome Testing Kit Market?
A microbiome testing kit refers to a diagnostic tool designed to analyze the microbial communities such as bacteria, viruses, and fungi present in a specific environment, often the human gut, skin, or oral cavity. These kits provide insights into an individual’s microbiome composition, helping assess health, nutrition, and potential risk factors for certain diseases. The main product types of microbiome testing kit are at-home testing kits and laboratory-based testing kits. At-home testing kits refer to diagnostic tools that allow individuals to collect and analyze their gut or other body microbiota samples at home to gain personalized insights into microbial composition, diversity, and overall health. It uses various sample types, including stool, saliva, skin, and other sample types, and is applied across multiple areas such as gut health, skin health, nutrition and diet, disease risk assessment, and other applications. It is distributed through online pharmacies, retail stores, and other channels, serving diverse end users such as individuals, hospitals and clinics, research and academic institutes, and others.
What Is The Microbiome Testing Kit Market Size and Share 2026?
The microbiome testing kit market size has grown exponentially in recent years. It will grow from $1.63 billion in 2025 to $2.03 billion in 2026 at a compound annual growth rate (CAGR) of 24.3%. The growth in the historic period can be attributed to advancements in microbiome research, consumer wellness trends, DNA sequencing accessibility, digestive health awareness, research funding growth.What Is The Microbiome Testing Kit Market Growth Forecast?
The microbiome testing kit market size is expected to see exponential growth in the next few years. It will grow to $4.8 billion in 2030 at a compound annual growth rate (CAGR) of 24.0%. The growth in the forecast period can be attributed to precision nutrition demand, AI-driven microbiome analytics, chronic disease prevention focus, e-commerce health platforms, personalized healthcare models. Major trends in the forecast period include growth of at-home diagnostic testing, personalized nutrition and wellness insights, expansion of gut health applications, preventive health screening adoption, increased consumer health awareness.Global Microbiome Testing Kit Market Segmentation
1) By Product Type: At-Home Testing, Laboratory-Based Testing 2) By Sample Type: Stool, Saliva, Skin, Other Sample Types 3) By Application: Gut Health, Skin Health, Nutrition And Diet, Disease Risk Assessment, Other Applications 4) By Distribution Channel: Online, Pharmacies, Retail Stores, Other Distribution Channel 5) By End-User: Individuals, Hospitals And Clinics, Research And Academic Institutes, Other End-Users Subsegments: 1) By At-Home Testing: Gut Health Analysis, Digestive Function Assessment, Personalized Nutrition Guidance, Probiotic Response Evaluation 2) By Laboratory-Based Testing Kits: Microbial Diversity Profiling, Pathogen Detection, Metabolic Activity Analysis, Antibiotic Resistance ScreeningWhat Is The Driver Of The Microbiome Testing Kit Market?
The increasing demand for personalized medicine is expected to propel the growth of the microbiome testing kit market going forward. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to an individual’s unique genetic makeup, lifestyle, and environment. The increasing adoption of personalized medicine is primarily due to advancements in genomics, which enable precise identification of genetic variations and tailored treatments for individuals. Microbiome testing kits enhance personalized medicine by offering individualized insights into a person’s microbial composition, making them ideal for tailored health management. They reduce guesswork in dietary and lifestyle interventions by providing precise, data-driven recommendations, improving overall wellness and disease prevention. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the microbiome testing kit industry.Key Players In The Global Microbiome Testing Kit Market
Major companies operating in the microbiome testing kit market are OraSure Technologies Inc., Genova Diagnostics Inc., Ombre Health Inc., Viome Inc., Zymo Research Corporation, EasyDNA Pty Ltd., Psomagen Inc., DayTwo Ltd., Atlas Biomed Group Limited., BIOHM Health Inc., Mapmygenome India Limited, Biomes NGS GmbH, Carbiotix AB, CosmosID Inc., Juno Bio Ltd., Microba Life Sciences Limited., Sun Genomics Inc., Unseen Bio ApS, InnerBuddies, MyMicroZoo B.V.Global Microbiome Testing Kit Market Trends and Insights
Major companies operating in the microbiome testing kit market are focusing on developing innovative solutions, such as next-generation sequencing-based gut microbiome analysis, to provide personalized insights into gut health and dietary recommendations. Next-generation sequencing-based gut microbiome analysis is a method that rapidly decodes the deoxyribonucleic acid of all microbes in the gut to identify their types, abundance, and potential impact on health. For instance, in January 2025, CJ Bioscience Inc., a South Korea-based biotechnology company, launched SMILE GUT, a direct-to-consumer gut microbiome testing kit designed to offer personalized insights into gut health. The kit employs next-generation sequencing and artificial intelligence to examine stool samples and generates a gut microbiome index score that reflects microbial diversity, the balance between beneficial and harmful bacteria, and alignment with healthy gut profiles. It provides tailored health recommendations, including probiotic guidance and dietary suggestions, with results delivered within 14 business days, enabling users to proactively manage their gut health.What Are Latest Mergers And Acquisitions In The Microbiome Testing Kit Market?
In January 2025, Pooch and Mutt Ltd., a UK-based pet food and treat company, acquired Biome9 for an undisclosed amount. With this acquisition, Pooch and Mutt aims to expand its science-backed pet nutrition offerings by providing personalized, microbiome-driven gut health solutions for dogs. Biome9 Limited is a UK-based company that offers a microbiome testing kit specifically designed for dogs, known as the gutdiscovery test.Regional Outlook
North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Microbiome Testing Kit Market?
The microbiome testing kit market consists of sales of respiratory microbiome kits, infant microbiome kits, environmental microbiome kits, sample preservation and transport kits, next-generation sequencing (NGS) panels, and data interpretation platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Microbiome Testing Kit Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.03 billion |
| Revenue Forecast In 2035 | $4.8 billion |
| Growth Rate | CAGR of 24.3% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Sample Type, Application, Distribution Channel, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | OraSure Technologies Inc., Genova Diagnostics Inc., Ombre Health Inc., Viome Inc., Zymo Research Corporation, EasyDNA Pty Ltd., Psomagen Inc., DayTwo Ltd., Atlas Biomed Group Limited., BIOHM Health Inc., Mapmygenome India Limited, Biomes NGS GmbH, Carbiotix AB, CosmosID Inc., Juno Bio Ltd., Microba Life Sciences Limited., Sun Genomics Inc., Unseen Bio ApS, InnerBuddies, MyMicroZoo B.V. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
